John Roy Bergman alias The Spinal Salesman

John Roy Bergman is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Heart disease develops unnoticed.

Heart disease develops unnoticed

Supports

There is substantial evidence that coronary artery disease and atherosclerosis can be present and progress in people without symptoms, supporting the idea that heart disease often develops unnoticed. Large cohort imaging studies such as PESA and Miami Heart demonstrate that a majority of middle‑aged, ostensibly healthy, asymptomatic individuals already have subclinical atherosclerosis or coronary plaque detected by vascular ultrasound or coronary calcium scoring, despite no prior cardiovascular events or symptoms.^{[21][15][18][20][19]} Observational data show that subclinical atherosclerosis burden and progression in asymptomatic adults are independently associated with all‑cause mortality, indicating clinically important disease that has developed before overt symptoms appear.^[19][20][25] Studies of coronary artery calcium and CT angiography in asymptomatic populations consistently find a high prevalence of coronary plaque and non‑significant stenosis, again reflecting that structural heart disease can be present and evolving without clinical manifestations.^{[3][16][17][18][9][10]} Work on silent myocardial ischemia indicates that a measurable proportion (around 2–5%) of totally asymptomatic middle‑aged individuals have occult ischemia on stress testing, further confirming that ischemic heart disease can exist without being noticed.^[22][24] Screening modalities (coronary calcium CT, CTA, carotid ultrasound) are being studied specifically to identify at‑risk asymptomatic individuals with subclinical disease and high‑risk plaques, directly premised on the recognition that heart disease commonly develops before symptoms prompt clinical attention.^{[1][6][7][8][19]}

Contradicts

Although subclinical coronary disease is common, the claim as stated (“heart disease develops unnoticed”) overgeneralizes and may be misunderstood as implying that heart disease invariably or exclusively develops without any detectable markers, which is not supported. Epidemiologic and imaging studies show that many individuals have traditional risk factors (hypertension, diabetes, dyslipidemia, smoking, family history) and measurable changes (coronary calcium, plaques) long before clinical events; these are detectable with routine risk assessment and guideline‑directed evaluation, so the process is not necessarily “unnoticed” when appropriate preventive care is applied.^{[3][6][19][21][25]} Silent ischemia is present only in a minority of asymptomatic people (roughly a few percent of middle‑aged men), meaning most people with significant ischemia either eventually develop symptoms or are identifiable via risk‑based testing; this weakens any interpretation that heart disease almost always progresses completely silently.^[22][24] Observational data on screening with coronary CTA suggest that while it can detect asymptomatic disease, its long‑term impact on hard cardiovascular outcomes over 5 years is limited or uncertain, indicating that simply having occult disease does not always equate to imminent events and that detection may modify risk trajectories.^[8] Overall, the evidence supports that early coronary disease is often clinically silent but does not support a blanket statement that heart disease universally develops unnoticed; rather, it frequently has detectable subclinical markers and risk factors that can be recognized with standard preventive care and guideline‑based management.^[0]

Mainstream view

The mainstream cardiovascular view is that atherosclerosis and coronary artery disease typically begin and progress as a subclinical process over many years, with plaques, coronary calcium, and even silent ischemia often present well before symptoms such as angina or myocardial infarction occur.^{[15][18][19][21][25]} Imaging cohorts in asymptomatic adults consistently show a high prevalence of coronary plaque and subclinical atherosclerosis, and these findings correlate with future cardiovascular events and mortality, so major societies emphasize risk‑factor assessment and, in selected groups, imaging to identify disease before it becomes clinically apparent.^{[18][19][20][21]} At the same time, guidelines stress that most risk stratification and prevention should rely on traditional risk factors (blood pressure, lipids, diabetes, smoking, family history) and global risk scores, reserving advanced imaging for specific risk categories, since routine screening of all asymptomatic individuals has not shown broad outcome benefits and may carry costs and risks.^[0][8][25] Thus, mainstream medicine recognizes that heart disease often develops in a largely asymptomatic, “unnoticed” way at the tissue level, but believes it can be anticipated and mitigated by systematic assessment and management of risk factors, and by targeted use of subclinical disease imaging in appropriate patients.

In their own wordsView sourceArchived copy

“heart disease for example, often develops unnoticed for many years before it strikes: in fact, the first symptom of heart disease that many people experience is a heart attack or death”

Rule: California Chiropractic Initiative Act, Bus. & Prof. Code Initiative Measure §7 (chiropractic defined)

John Roy Bergman is not licensed or approved by California Board of Chiropractic Examiners to diagnose, treat, or cure Nutritional Counseling.

Nutritional Counseling

Supports

The broad, generic claim “Nutritional Counseling” is too vague, but high‑quality evidence does support specific roles for individualized nutrition counseling in defined clinical settings. ^[10][11] In inflammatory bowel disease, the ESPEN guideline on clinical nutrition recommends that patients in remission receive counseling by a dietitian as part of multidisciplinary care to improve nutritional therapy and prevent malnutrition and nutrition-related disorders, indicating a guideline-level endorsement of nutritional counseling in this context. ^[3] In oncology, a systematic review and meta-analysis of oral nutritional interventions during chemo(radio)therapy found that nutrition support, often including counseling plus supplements, can improve nutritional status and clinical outcomes, although the evidence is heterogeneous and methodologically limited. ^[9][13] A systematic review of nutritional counseling in adult cancer patients undergoing treatment found that individualized and intensive counseling can improve or at least attenuate deterioration in body weight and fat-free mass at certain time points, with good patient satisfaction, supporting its use for nutritional and anthropometric endpoints. ^[12] Another systematic review of nutrition interventions in older cancer patients reported that dietary counseling may improve quality of life, even though effects on hard clinical endpoints are modest. ASPEN–FELANPE clinical guidelines for nutrition in critical illness and related settings emphasize structured nutrition assessment and intervention, including counseling, as part of standard care to prevent or treat malnutrition, which reflects strong consensus about its importance in high-risk patients. ^[2] The ESPEN IBD guideline also supports systematic nutrition assessment and dietetic involvement to manage malnutrition, micronutrient deficiencies, and diet-related issues, implying an embedded role for nutrition counseling in routine management. ^[1]

Contradicts

Although there is supportive evidence in several conditions, high-quality data for nutritional counseling alone are inconsistent and often show only modest benefits on hard outcomes. ^[10] In oncology, the systematic review of oral nutritional interventions during chemo(radio)therapy concluded that, despite some positive findings, evidence quality is limited and heterogeneous, and more rigorous trials are needed to define clinical impact beyond nutritional parameters. ^[9][2] A systematic review of nutritional interventions in older cancer patients found that while counseling may improve quality of life, overall benefits of dietary interventions in negating poor survival or treatment completion are limited, indicating that counseling is not a powerful stand-alone therapeutic for major clinical outcomes. ^[11][12][13] Broader reviews of dietary interventions in cancer note that most randomized trials are small, often focus on surrogate endpoints (dietary intake, body composition), and large RCTs have not demonstrated clear improvements in cancer outcomes, so there is currently limited evidence to support dietary interventions, including counseling, as a primary therapeutic tool in cancer care. Even within specific cancer populations such as head and neck cancer, systematic reviews of individualized dietary counseling report low-quality evidence with high risk of bias and heterogeneous results, with some trials showing improved nutritional status and quality of life and others showing no significant changes. Overall, while nutritional counseling is feasible and often improves intake and some patient-reported or surrogate outcomes, robust evidence that it consistently changes major endpoints like survival, hospitalization, or long-term disease progression is weak or lacking in many disease areas, so any blanket claim that “nutritional counseling” broadly and strongly improves all health outcomes is not supported by current evidence.

Mainstream view

Mainstream medical and scientific opinion is that nutritional counseling is an important component of comprehensive care in many chronic and acute conditions, primarily to optimize dietary intake, prevent or treat malnutrition, and support quality of life, but it is generally considered adjunctive rather than a stand-alone curative therapy. ^[10] Major guidelines in clinical nutrition, including ASPEN–FELANPE and ESPEN, explicitly integrate structured nutrition assessment and individualized counseling by qualified dietitians into standard care for high-risk populations such as patients with inflammatory bowel disease and those at risk of or with established malnutrition. ^[2][3][11] In oncology, systematic reviews support offering individualized nutritional counseling—often together with oral supplements—to improve or maintain nutritional status and, in some contexts, quality of life, while acknowledging that evidence for improvement in hard outcomes like survival or treatment completion is modest and inconsistent. ^[9][12][13] Consequently, the mainstream position is that nutritional counseling is evidence-supported for improving diet quality, intake, nutritional status, and some patient-centered outcomes in selected populations, and should be delivered by trained professionals within multidisciplinary care, but its benefits are condition-specific, of varying magnitude, and not a substitute for disease-specific medical or surgical treatments.

In their own wordsView sourceArchived copy

“we provide specific recommendations on nutritional supplements and healthy food choices”

Rule: Cal. Bus. & Prof. Code §1000; 16 CCR §302

John Roy Bergman is not licensed or approved by California Board of Chiropractic Examiners to advertise Nutritional Counseling for systemic health as within their scope of practice.

Nutritional Counseling for systemic health

Supports

The broad, generic claim “Nutritional Counseling” is too vague, but high‑quality evidence does support specific roles for individualized nutrition counseling in defined clinical settings. ^[10][11] In inflammatory bowel disease, the ESPEN guideline on clinical nutrition recommends that patients in remission receive counseling by a dietitian as part of multidisciplinary care to improve nutritional therapy and prevent malnutrition and nutrition-related disorders, indicating a guideline-level endorsement of nutritional counseling in this context. ^[3] In oncology, a systematic review and meta-analysis of oral nutritional interventions during chemo(radio)therapy found that nutrition support, often including counseling plus supplements, can improve nutritional status and clinical outcomes, although the evidence is heterogeneous and methodologically limited. ^[9][13] A systematic review of nutritional counseling in adult cancer patients undergoing treatment found that individualized and intensive counseling can improve or at least attenuate deterioration in body weight and fat-free mass at certain time points, with good patient satisfaction, supporting its use for nutritional and anthropometric endpoints. ^[12] Another systematic review of nutrition interventions in older cancer patients reported that dietary counseling may improve quality of life, even though effects on hard clinical endpoints are modest. ASPEN–FELANPE clinical guidelines for nutrition in critical illness and related settings emphasize structured nutrition assessment and intervention, including counseling, as part of standard care to prevent or treat malnutrition, which reflects strong consensus about its importance in high-risk patients. ^[2] The ESPEN IBD guideline also supports systematic nutrition assessment and dietetic involvement to manage malnutrition, micronutrient deficiencies, and diet-related issues, implying an embedded role for nutrition counseling in routine management. ^[1]

Contradicts

Although there is supportive evidence in several conditions, high-quality data for nutritional counseling alone are inconsistent and often show only modest benefits on hard outcomes. ^[10] In oncology, the systematic review of oral nutritional interventions during chemo(radio)therapy concluded that, despite some positive findings, evidence quality is limited and heterogeneous, and more rigorous trials are needed to define clinical impact beyond nutritional parameters. ^[9][2] A systematic review of nutritional interventions in older cancer patients found that while counseling may improve quality of life, overall benefits of dietary interventions in negating poor survival or treatment completion are limited, indicating that counseling is not a powerful stand-alone therapeutic for major clinical outcomes. ^[11][12][13] Broader reviews of dietary interventions in cancer note that most randomized trials are small, often focus on surrogate endpoints (dietary intake, body composition), and large RCTs have not demonstrated clear improvements in cancer outcomes, so there is currently limited evidence to support dietary interventions, including counseling, as a primary therapeutic tool in cancer care. Even within specific cancer populations such as head and neck cancer, systematic reviews of individualized dietary counseling report low-quality evidence with high risk of bias and heterogeneous results, with some trials showing improved nutritional status and quality of life and others showing no significant changes. Overall, while nutritional counseling is feasible and often improves intake and some patient-reported or surrogate outcomes, robust evidence that it consistently changes major endpoints like survival, hospitalization, or long-term disease progression is weak or lacking in many disease areas, so any blanket claim that “nutritional counseling” broadly and strongly improves all health outcomes is not supported by current evidence.

Mainstream view

Mainstream medical and scientific opinion is that nutritional counseling is an important component of comprehensive care in many chronic and acute conditions, primarily to optimize dietary intake, prevent or treat malnutrition, and support quality of life, but it is generally considered adjunctive rather than a stand-alone curative therapy. ^[10] Major guidelines in clinical nutrition, including ASPEN–FELANPE and ESPEN, explicitly integrate structured nutrition assessment and individualized counseling by qualified dietitians into standard care for high-risk populations such as patients with inflammatory bowel disease and those at risk of or with established malnutrition. ^[2][3][11] In oncology, systematic reviews support offering individualized nutritional counseling—often together with oral supplements—to improve or maintain nutritional status and, in some contexts, quality of life, while acknowledging that evidence for improvement in hard outcomes like survival or treatment completion is modest and inconsistent. ^[9][12][13] Consequently, the mainstream position is that nutritional counseling is evidence-supported for improving diet quality, intake, nutritional status, and some patient-centered outcomes in selected populations, and should be delivered by trained professionals within multidisciplinary care, but its benefits are condition-specific, of varying magnitude, and not a substitute for disease-specific medical or surgical treatments.

In their own wordsView sourceArchived copy

“we provide specific recommendations on nutritional supplements and healthy food choices”

Rule: Cal. Bus. & Prof. Code §1000; 16 CCR §302